Logo of Huzzle

Vertex Summer 2024 Intern, DCAT - San Diego, CA

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Software Engineering
  • San Diego

Requirements

  • Currently enrolled in a B.S. degree program
  • Software engineering related background
  • SQL, C#, JavaScript, HTML, CSS
  • Ability to interface and maintain effective relationships with the team
  • Strong written and verbal communication skills
  • UX/UI design
  • Python
  • Knowledge of configuration management tools (e.g. Subversion, Git, etc.)
  • Legally authorized to work in the United States
  • Candidate must be enrolled in an advanced degree program if graduating in Spring 2024

Responsibilities

  • Learn lab workflows that are currently manual
  • Interpret and contribute to design specification development
  • Collaborate with DCAT to implement software solutions that meet end user’s needs
  • Use critical thinking to tackle challenges unique to the biotech industry

The Science of Possibility

Science & Healthcare
Industry
1001-5000
Employees
1989
Founded Year

Mission & Purpose

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.